Company Overview - The company specializes in high-quality health supplements and personal care products, certified by multiple international standards, including TGA and GMP[12]. - The company has received recognition as a "Hong Kong Excellent Brand" and has been acknowledged as a quality merchant by the Hong Kong Tourism Board for 15 consecutive years[12]. - The business has shown steady growth, supported by strong market acceptance in Hong Kong and across Asia[12]. Market Presence and Sales Strategy - As of March 31, 2023, the company operates 17 specialty stores and 60 consignment counters in Hong Kong, Macau, and Singapore, establishing a solid foundation in the region[19]. - The company has expanded its online sales strategy, enhancing its official website and custom app to improve customer experience and loyalty[15]. - The company has partnered with various e-commerce platforms, including HKTVmall and Tmall, significantly increasing market penetration[16]. - The introduction of the "Omnichat" promotional software has improved customer interaction and communication, allowing for precise promotional targeting[15]. - The company has established a cross-border e-commerce experience store in Shenzhen, further enhancing its market presence[19]. Social Responsibility and Community Engagement - The company is committed to social responsibility, actively participating in community initiatives and promoting healthy lifestyles[26]. - The company actively promotes sports activities among employees and their families, contributing to work-life balance[34]. - The company has established a karate dojo to promote the sport and has achieved notable results in local competitions, including championships in various categories[34]. - The company emphasizes social responsibility and has been involved in various charitable activities, including donations to support underprivileged students[41]. - The company supports anti-drug initiatives and has participated in events to educate youth about drug prevention[36]. - The company has organized various employee engagement activities, such as movie screenings and concerts, to foster a positive workplace culture[42]. - The company has been involved in community sports projects to encourage healthy lifestyles and support local sports development[38]. - The company has provided financial assistance to economically disadvantaged students and participated in educational seminars[51]. - The company’s chairman has been actively involved in community service and youth education initiatives, sharing experiences and insights[41]. - The company has sponsored local karate competitions and supported the Hong Kong Karate Association in organizing events[34]. - The company has a commitment to nurturing future leaders through educational support and community engagement[41]. Financial Performance - The company reported a revenue increase of 13.5% to HKD 146,158,000 for the fiscal year ending March 31, 2023, compared to the previous year[103]. - The company achieved a consolidated profit of HKD 497,000, recovering from a loss of HKD 843,000 in the previous year[103]. - The board proposed a final cash dividend of HKD 0.01 per share to reward shareholders for their support[103]. - Revenue from health supplement products increased by 15.3% to HKD 141,400,000, while personal care products and honey/pollen products saw declines of 26.3% and 10.4%, respectively[117]. - Sales through specialty stores and consignment counters increased by 7.8% to HKD 39,890,000 and 27.0% to HKD 79,829,000, respectively, driven by the influx of travelers from mainland China[119]. - The group's gross profit margin slightly improved to 82.9% from 81.7% in the previous year, despite a 5.7% increase in cost of sales to HKD 24,924,000[120]. - Other income rose by 107.9% to HKD 4,238,000, primarily due to increased government subsidies and bank interest income[120]. - The income tax expense for the year was HKD 663,000, a shift from an income tax credit of HKD 2,123,000 in the previous year, reflecting the transition from a loss to a profit[124]. Future Outlook and Strategic Initiatives - The company plans to launch new diversified products to meet the varying needs of target customers[105]. - Strategic partnerships have been established with suppliers and businesses to expand both online and physical sales networks[105]. - The company aims to recruit and build a dynamic team in various regions to support its diversified business development[105]. - The group plans to expand its product portfolio to cater to changing customer preferences and enhance customer health[138]. - The integration of online and offline sales remains a key focus, aiming to improve customer experience and loyalty[140]. - The group will continue to streamline inventory levels and optimize its physical store network to enhance operational efficiency[138]. - The company is expanding its market presence in Southeast Asia, aiming to increase market share by 30% in the region over the next two years[154]. - A strategic acquisition of a local health food brand is in progress, which is anticipated to enhance the product portfolio and increase market penetration[154]. - Investment in technology development is set at HKD 50 million, aimed at improving online sales channels and customer engagement platforms[154]. - The company plans to enhance its marketing strategies, allocating 10% of revenue towards digital marketing initiatives to boost brand visibility[154]. - The management team has emphasized a commitment to sustainability, with plans to reduce carbon emissions by 15% over the next three years[154]. Governance and Corporate Structure - The company has a strong governance structure with over 40% of the board members being independent non-executive directors[170]. - The board consists of seven members, including the chairman and co-CEOs, ensuring a balance of executive and independent oversight[170]. - The company has adopted a standard code for securities trading by directors, confirming compliance throughout the year[165]. - The management team is led by a finance director with over 20 years of experience in accounting services[160]. - The company emphasizes accountability and risk management as part of its corporate governance practices[163]. - The independent non-executive directors contribute significant business and financial expertise to the board[171]. - The company has appropriate insurance coverage for potential legal claims against directors[173]. - The finance team is responsible for overseeing corporate financing, treasury, financial reporting, and tax matters[157]. - The company has established various board committees to delegate responsibilities effectively[166]. - The management is tasked with executing the business plans and strategies adopted by the board[166]. - The board held 4 meetings during the year, including the approval of the audited consolidated financial statements for the year ended March 31, 2022, and the unaudited consolidated financial statements for the six months ended September 30, 2022[175]. - All directors attended 100% of the board meetings, with each director present for all 4 meetings[178]. - The audit committee held 3 meetings during the year, including the review and approval of the audited consolidated financial statements for the year ended March 31, 2022[185]. - The audit committee consists of three independent non-executive directors, ensuring compliance with corporate governance codes and listing rules[181]. - The remuneration committee was established on July 20, 2016, and includes two independent non-executive directors and one executive director[187]. - The company encourages all directors to participate in training courses, with costs covered by the company, to enhance their understanding of corporate governance responsibilities[174]. - The chairman and co-CEO's dual role is deemed in the best interest of the group, with all major decisions made after consulting the entire board[179]. - The company has established three committees under the board: audit committee, remuneration committee, and nomination committee, to oversee specific aspects of the company's affairs[180]. - The audit committee's responsibilities include monitoring the integrity of financial statements and reviewing risk management and internal control systems[183]. - The company held one annual general meeting and one special general meeting during the year, with full attendance from all directors[178]. - The Compensation Committee held 3 meetings during the year to review and approve the remuneration proposals for directors and senior management[190]. - Attendance records for the Compensation Committee meetings show that all directors attended all 3 meetings[191]. - The Nomination Committee was established on July 20, 2016, and includes two independent non-executive directors and one executive director[192]. - The Nomination Committee held 2 meetings during the year to evaluate the board's structure, size, and composition[196]. - Attendance records for the Nomination Committee meetings indicate full attendance by all directors[197]. - The Nomination Committee's responsibilities include reviewing and approving compensation arrangements for directors dismissed for misconduct[193]. - The Nomination Committee assesses the independence of independent non-executive directors[194]. - The company emphasizes the importance of diversity in the board's composition, considering various factors such as gender and professional background[199]. - The company aims to ensure that candidates possess relevant skills, knowledge, and experience related to its business[199]. - The Nomination Committee follows a structured process for nominating candidates for board appointments or shareholder elections[198].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而 產生或因依賴該等內容而引致的任何損失承擔任何責任。 Ausupreme International Holdings Limited 澳 至 尊 國 際 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：2031） 截至2023年3月31日止年度 全年業績公佈 澳至尊國際控股有限公司（「本公司」）董事（「董事」）會（「董事會」）提呈本公司及其附屬公 司（統稱為「本集團」）截至2023年3月31日止年度（「本年度」或「年內」）之綜合業績，連同 截至2022年3月31日止年度（「2022年度」）之比較數據。 綜合損益及其他全面收益表 截至2023年3月31日止年度 截至3月31日止年度 2023年 2022年 附註 千港元 千港元 收益 4 146,158 128,726 銷售成本 (24,924) (23,580) ...

Financial Performance - Revenue for the six months ended September 30, 2022, was HKD 61,292,000, a decrease of 3.5% from HKD 63,392,000 in the same period of 2021[4] - Gross profit for the same period was HKD 51,117,000, down from HKD 52,500,000, reflecting a decline of 2.6%[4] - The company reported a loss before tax of HKD 433,000 compared to a profit of HKD 51,000 in the previous year[4] - The net loss for the period was HKD 365,000, compared to a loss of HKD 209,000 in the prior year, indicating a 74.9% increase in losses[4] - The company reported a total revenue of HKD 61,292 thousand for the six months ended September 30, 2022, a decrease of 3.3% from HKD 63,392 thousand in the same period of 2021[32] - Revenue from health supplement products was HKD 59,267 thousand, while personal care products and honey & pollen products generated HKD 1,268 thousand and HKD 757 thousand, respectively[32] - The group reported a net loss of HKD 365,000 attributable to owners for the six months ended September 30, 2022, compared to a loss of HKD 209,000 for the same period in 2021[57] - The group recorded a loss attributable to owners of HKD 365,000, compared to a loss of HKD 209,000 in the same period last year, primarily due to foreign exchange losses and reduced revenue from the Macau division[88] - The basic loss per share for the six months ended September 30, 2022, was HKD 0.05, compared to HKD 0.03 for the same period last year[100] Assets and Liabilities - Total assets as of September 30, 2022, were HKD 127,634,000, a slight decrease from HKD 130,837,000 as of March 31, 2022[10] - The company's net asset value decreased to HKD 155,688,000 from HKD 166,565,000, representing a decline of 6.5%[12] - The company’s cash and cash equivalents decreased to HKD 38,794,000 from HKD 56,156,000, a decline of 30.9%[10] - The company’s inventory increased to HKD 20,197,000 from HKD 15,098,000, representing a rise of 33.8%[10] - Accounts receivable as of September 30, 2022, amounted to HKD 8,144 million, an increase of 11.4% from HKD 7,312 million as of March 31, 2022[66] - Total liabilities as of September 30, 2022, were HKD 11,294 million, a decrease of 16% from HKD 13,394 million as of March 31, 2022[71] - The company's issued and fully paid share capital remained at HKD 7,620 million with 762 million shares as of September 30, 2022, unchanged from March 31, 2022[76] Cash Flow and Investments - The operating cash flow before tax was a loss of HKD 433 thousand for the six months ended September 30, 2022, compared to a profit of HKD 51 thousand in the same period of 2021[19] - The net cash used in operating activities was HKD 1,640 thousand for the six months ended September 30, 2022, a significant decline from HKD 9,758 thousand in the previous year[19] - The company reported a net cash outflow from investing activities of HKD 8,043 thousand for the six months ended September 30, 2022, compared to an inflow of HKD 22,688 thousand in the same period of 2021[19] - The company’s cash and cash equivalents decreased to HKD 38,794 thousand as of September 30, 2022, down from HKD 85,239 thousand at the same time in 2021[22] - The company incurred a net foreign exchange loss of HKD 1,226,000 for the six months ended September 30, 2022, compared to a gain of HKD 258,000 in the previous year[44] - The group recognized government subsidies of approximately HKD 2,502,000 under the Hong Kong government's employment support scheme for the six months ended September 30, 2022[40] - Other income for the six months ended September 30, 2022, included bank interest income of HKD 147,000, government subsidies of HKD 2,505,000, and rental concessions of HKD 535,000[39] Operational Highlights - The group has one operating segment, which is the retail and wholesale of health and personal care products[37] - The group has 18 specialty stores and 63 consignment counters as of September 30, 2022, with 12 consignment counters still closed due to COVID-19 restrictions[89] - The group is actively reviewing and enhancing its business plans to adapt to the changing business environment and mitigate risks posed by the COVID-19 pandemic[88] - The overall retail sales in Hong Kong recorded a slight growth of 2.1% during the period, but the positive impact of government consumption voucher schemes is diminishing[85] Expenses and Dividends - Other comprehensive expenses for the period totaled HKD 3,257,000, compared to HKD 1,527,000 in the previous year, reflecting a significant increase of 113.4%[7] - The company paid dividends amounting to HKD 7,620 thousand during the period[17] - The group did not declare an interim dividend for the six months ended September 30, 2022, consistent with the previous year[55] - Sales and distribution expenses slightly increased by 0.4% to HKD 39,330,000, while general and administrative expenses rose by 2.8% to HKD 14,234,000[97] Corporate Governance - The audit committee consists of three independent non-executive directors responsible for reviewing the financial reporting system and internal control procedures[137] - The company has complied with all provisions of the corporate governance code, except for the separation of the roles of chairman and CEO[132] - The company has maintained a public float of at least 25% of its total issued shares throughout the reporting period[136] Employee and Market Insights - The company employed 167 staff as of September 30, 2022, an increase from 158 staff as of March 31, 2022[109] - The unemployment rate in Hong Kong decreased from 3.9% to 3.8% between July-September 2022 and August-October 2022, indicating a continued improvement in the labor market[112] - The company is implementing stricter cost control measures and reallocating physical store locations and manpower to enhance operational efficiency amid economic uncertainties[112]

Financial Performance - AUSupreme reported a revenue increase of 15% year-over-year, reaching HKD 500 million for the fiscal year 2021-22[12] - The company achieved a gross profit margin of 40%, reflecting improved operational efficiency compared to the previous year[12] - The company reported a net profit of HKD 100 million, a 10% increase from the previous fiscal year[12] - For the fiscal year ending March 31, 2022, the company's revenue was HKD 128,726,000, representing a 25.1% increase from HKD 102,907,000 in 2021[67] - The company recorded a loss of HKD 843,000 for the year, compared to a profit of HKD 3,844,000 in the previous year, primarily due to the absence of COVID-19 related government subsidies and reduced rental income[67] - Revenue from health supplement products increased by 25.4% to HKD 122,675,000, accounting for 95.3% of total revenue[70] Market Expansion and Strategy - AUSupreme plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share over the next two years[12] - Future guidance estimates a revenue growth of 20% for the upcoming fiscal year, driven by new product launches and market expansion[12] - The company aims to continue expanding its market presence in Asia, focusing on becoming a leading health brand[26] - The company emphasizes a diversified market strategy, particularly in local and cross-border e-commerce[27] - The company is exploring potential acquisition opportunities in the health and wellness sector to diversify its product offerings[12] Product Development and Innovation - The company is investing HKD 50 million in new product development, focusing on health supplements and wellness products[12] - The company is focused on developing online sales channels and maintaining its enterprise resource planning systems[108] - The company is exploring new product development and technological advancements to enhance its market position[116] Online Sales and E-commerce - The company has accelerated online sales development, launching a new official website and a customized app to enhance customer experience[27] - The online shopping experience was enhanced with a new official website, focusing on e-commerce and social media platforms to boost sales and brand awareness[61] - The company plans to invest more resources into interest-based e-commerce, particularly through platforms like Douyin, to leverage their large user base and recommendation technology[94] Corporate Social Responsibility - The company is committed to social responsibility, actively engaging in community support initiatives and educational programs[28] - The company has been involved in anti-drug campaigns, promoting a healthy lifestyle within the community[29] - The company remains committed to social contributions, including donations of health supplies and support for educational initiatives during the pandemic[61] Governance and Management - The company has a robust governance structure with independent directors providing oversight and strategic guidance[112] - The board consists of seven directors, with independent non-executive directors accounting for over 40% of the board members[125] - The company has established a clear framework for the appointment and evaluation of board members to align with corporate strategy[150] Awards and Recognition - The company has received multiple awards and certifications, including the "Hong Kong Excellent Brand" and "Outstanding Listed Company Award," highlighting its market value and industry recognition[41][46] - The company has been recognized for its commitment to sustainable development and corporate social responsibility, receiving accolades such as the "Sustainable Supply Chain Leader" award[48] - The company has been acknowledged as a leading brand in the health supplement industry, receiving the "Asia Excellent Brand" award for its innovative practices[51] Challenges and Risks - The company anticipates continued volatility in the business environment due to ongoing pandemic effects and geopolitical tensions, but expects to benefit from new government consumption voucher programs[62] - The company is prepared for business development in the upcoming years, leveraging its solid foundation[96] - Management acknowledges the operational dependency on third parties may lead to service deterioration or errors[200] - Potential risks include damage to reputation, business interruptions, and financial losses[200] Employee Engagement and Development - The company has established a healthy and vibrant work environment, encouraging employee participation in physical activities, which has been recognized by the "Corporate Together Action Award" program[58] - The company has maintained a strong focus on employee training and development, achieving the "Super MD" status for ten consecutive years[46] - The company has a commitment to employee training and development, as evidenced by its mentorship programs[107]

Financial Performance - Revenue for the six months ended September 30, 2021, was HKD 63,392,000, an increase of 54% compared to HKD 41,190,000 for the same period in 2020[6] - Gross profit for the same period was HKD 52,500,000, up from HKD 33,713,000, reflecting a gross margin improvement[6] - Operating profit decreased to HKD 228,000 from HKD 3,385,000, indicating challenges in operational efficiency[6] - The company reported a loss attributable to owners of the company of HKD 260,000, compared to a profit of HKD 2,810,000 in the previous year[6] - The company incurred a loss of HKD 209,000 during the six months ended September 30, 2021, compared to a profit of HKD 2,810,000 in the same period of 2020[12] - The group reported total revenue of HKD 63,392,000 for the six months ended September 30, 2021, compared to HKD 41,190,000 for the same period in 2020, representing a year-over-year increase of 54%[25] - Revenue from health supplements reached HKD 60,723,000, up from HKD 39,228,000 in the previous year, indicating a growth of 55%[26] - The group generated other income of HKD 484,000, significantly down from HKD 9,193,000 in the prior period, reflecting a decrease of approximately 95%[32] - The group’s pre-tax profit was impacted by a decrease in bank interest income, which fell to HKD 77,000 from HKD 698,000 year-over-year, a decline of 89%[32] - The total cost of inventory for the period was HKD 10,892,000, an increase from HKD 7,477,000 in the same period last year, representing a rise of 46%[36] - The group’s total tax expense for the six months ended September 30, 2021, was HKD 260,000, slightly down from HKD 261,000 in the prior year[38] Assets and Liabilities - Total assets as of September 30, 2021, were HKD 170,463,000, down from HKD 179,905,000 as of March 31, 2021[10] - Net asset value decreased to HKD 167,080,000 from HKD 176,227,000, indicating a decline in shareholder equity[10] - Current liabilities increased to HKD 31,040,000 from HKD 22,266,000, reflecting higher operational obligations[10] - The company’s total liabilities increased to HKD 12,121,000 as of September 30, 2021, from HKD 9,988,000 as of March 31, 2021[54] - The company’s receivables amounted to HKD 9,405,000 as of September 30, 2021, down from HKD 11,109,000 as of March 31, 2021[48] - The fair value of equity investments classified as other comprehensive income decreased to HKD 4,222,000 as of September 30, 2021, from HKD 5,506,000 as of March 31, 2021[45] - The company’s accounts payable increased significantly to HKD 4,120,000 as of September 30, 2021, from HKD 1,700,000 as of March 31, 2021[54] Cash Flow and Liquidity - The company’s cash and cash equivalents stood at HKD 85,239,000, an increase from HKD 59,987,000, indicating improved liquidity[10] - The net cash generated from operating activities was HKD 9,758,000 for the six months ended September 30, 2021, a decrease from HKD 15,734,000 in the prior year[15] - The company’s operating cash flow before changes in working capital was HKD 7,206,000, down from HKD 11,856,000 in the previous year[15] - The company reported a significant increase in cash and cash equivalents, totaling HKD 85,239,000 at the end of the period, compared to HKD 63,561,000 a year earlier, representing a growth of approximately 34%[15] Strategic Outlook - The company plans to focus on new product development and market expansion strategies in the upcoming periods[6] - Future outlook remains cautious due to market volatility and operational challenges faced during the reporting period[6] - The company plans to continue expanding its market presence in Hong Kong and enhance its product offerings in the health and personal care sector[17] - The group plans to strategically expand its physical sales network into prime retail locations and hire professional health consultants to enhance customer experience and drive sales[87] - The group is actively implementing various marketing initiatives, including attractive promotional activities and social media engagement, to attract new customers and improve customer loyalty[87] - The management acknowledges that the pandemic and other macroeconomic variables may affect the speed of market recovery but remains committed to providing quality products and services[87] Shareholder Information - The company did not declare an interim dividend for the six months ended September 30, 2021, compared to no dividend declared in 2020[42] - As of September 30, 2021, Beatitudes International Ltd. holds 425,340,000 shares, representing approximately 55.82% of the company's issued share capital[93] - Mr. Gao holds 89,225,000 shares, accounting for about 11.71% of the company's equity as of September 30, 2021[94] - Following a placement agreement, Beatitudes' shareholding decreased from 562,500,000 shares (approximately 73.82%) to 425,340,000 shares (approximately 55.82%) after the completion of the placement on September 13, 2021[93] - The average number of issued ordinary shares remained constant at 762,000,000 for both periods[43] - A total of 137,160,000 shares were successfully placed to 21 subscribers, resulting in 247,435,000 shares (approximately 32.47% of the company's issued share capital) held by public shareholders[105] - As of September 30, 2021, public holdings accounted for no less than 25% of the total issued shares[107] Corporate Governance - The company has complied with all provisions of the corporate governance code during the reporting period, except for the exception regarding the roles of the chairman and CEO[101] - The audit committee, composed of three independent non-executive directors, is responsible for reviewing and supervising the financial reporting system and internal control procedures of the group[108]

Financial Performance - AUSupreme reported a revenue of HKD 200 million for the fiscal year 2020-2021, representing a 15% increase compared to the previous year[22]. - The company achieved a gross profit margin of 40%, up from 35% in the prior year, indicating improved operational efficiency[22]. - The group’s revenue for the year ended March 31, 2021, was HKD 102,907,000, a decrease of 51.1% from HKD 210,543,000 in 2020[66]. - The profit attributable to the company's owners for the year was HKD 3,844,000, down 68.1% from HKD 12,047,000 in 2020[68]. - Revenue from health supplement products decreased by 49.8% to HKD 97,846,000, compared to HKD 194,770,000 in 2020[70]. - Revenue from personal care products fell by 74.7% to HKD 3,240,000, down from HKD 12,811,000 in 2020[70]. - Revenue from consignment counters dropped by 70.8% to HKD 47,382,000, compared to HKD 162,279,000 in 2020[74]. - E-commerce revenue increased by 74.7% to HKD 16,563,000, up from HKD 9,481,000 in 2020[74]. - Basic earnings per share for the year were HKD 0.50, down from HKD 1.60 in 2020[78]. Market Expansion and Product Development - AUSupreme plans to launch three new products in the next quarter, targeting a market expansion of 20% in the health supplement sector[22]. - The company is exploring potential acquisitions to expand its market presence in Southeast Asia, with a target completion date by Q3 2022[22]. - The company aims to expand its market presence both domestically and internationally, striving to build a well-known health brand in Asia[30]. - New product launches are anticipated to contribute an additional $C million in revenue, with a focus on expanding the health supplement product line[101]. - Market expansion plans include entering E new markets, with an expected increase in market share of F% within the next year[101]. - The company is exploring market expansion opportunities in international regions, targeting a growth rate of DD% in those markets[112]. Operational Efficiency and Cost Management - AUSupreme's operating expenses decreased by 5% due to cost-cutting measures and improved supply chain management[22]. - Total sales and distribution expenses decreased by 47.1% to HKD 73,620,000, compared to HKD 139,173,000 in 2020[75]. - Operational efficiency improvements are expected to reduce costs by GG%, contributing to overall profitability[112]. Sustainability and Social Responsibility - The company emphasized its commitment to sustainability, with plans to reduce carbon emissions by 25% over the next five years[22]. - The company has maintained a commitment to social responsibility, providing sufficient protective equipment and health products to employees during the COVID-19 pandemic[35]. - The management team emphasized a commitment to sustainability and corporate social responsibility initiatives, which are expected to resonate with consumers and drive brand loyalty[101]. - The board's report includes a commitment to environmental sustainability, aiming to minimize environmental impact through resource conservation and waste reduction policies[200]. Marketing and Sales Strategy - The company has implemented new marketing strategies, resulting in a 30% increase in online sales channels[22]. - The company has expanded its online sales strategy, partnering with various e-commerce platforms including HKTVmall, Tmall, JD.com, and Shopee, significantly increasing market penetration[31]. - The company focuses on community marketing and short video marketing to adapt to market changes and consumer psychology, aiming to create new momentum for development[60]. - The group plans to leverage digital technology and social media for marketing, including live streaming and engaging key opinion consumers (KOCs) to enhance customer experience[92]. Corporate Governance - The management team emphasized the importance of corporate governance and accountability in driving shareholder value[117]. - The board of directors includes a diverse range of expertise, with over 40% of members being independent non-executive directors, ensuring effective oversight[123]. - The audit committee is responsible for monitoring the integrity of the company's financial statements and reviewing significant judgments made in financial reporting[137]. - The company has established three committees under the board: the audit committee, remuneration committee, and nomination committee, to oversee specific aspects of the company's affairs[134]. - The board believes that the current structure, with Mr. Tsai as both chairman and co-CEO, serves the best interests of the group[133]. Employee and Operational Metrics - The group employed 164 staff as of March 31, 2021, a decrease from 201 in 2020[88]. - The company has a strong commitment to employee safety and health, implementing emergency measures during the pandemic to ensure operational continuity[35]. - The company has adopted a hybrid sales model combining online and offline strategies to adapt to changing market conditions due to the pandemic[31]. Awards and Recognition - The company has been recognized with multiple awards, including the "Hong Kong Excellent Brand" and "Parents' Favorite Supplement Brand" for its quality products[39]. - The company has received multiple awards for its brand image and product quality, enhancing its reputation in the health supplement industry[101]. - The company has received multiple awards recognizing its excellence in brand development and service quality, reinforcing its reputation in the health food industry[44][45][54].

Financial Performance - For the six months ended September 30, 2020, AUSupreme reported revenue of HKD 41,190,000, a decrease of 66.8% compared to HKD 124,006,000 for the same period in 2019[8]. - Gross profit for the same period was HKD 33,713,000, down 68.4% from HKD 106,698,000 year-over-year[8]. - Operating profit decreased to HKD 3,385,000, a decline of 70.8% compared to HKD 11,603,000 in the previous year[8]. - Profit attributable to owners of the company was HKD 2,810,000, down 68.5% from HKD 8,922,000 in the prior year[8]. - The company reported total assets of HKD 182,809,000 as of September 30, 2020, a decrease from HKD 190,821,000 as of March 31, 2020[11]. - Net assets attributable to owners of the company were HKD 176,368,000, down from HKD 181,666,000 at the end of the previous fiscal year[11]. - The company’s basic and diluted earnings per share for the period were HKD 0.37, compared to HKD 1.19 in the same period last year[8]. - Other comprehensive income for the period was HKD 2,322,000, down from HKD 8,898,000 in the prior year[8]. - The total comprehensive income for the period was HKD 2,322,000, after accounting for a foreign exchange loss of HKD (505,000)[13]. - The company's profit attributable to owners for the six months ended September 30, 2020, was HKD 2,810,000, a decrease of 68.5% compared to HKD 8,922,000 for the same period in 2019[47]. - Basic earnings per share for the period were HKD 0.37, down from HKD 1.19 in 2019, calculated based on the number of shares issued of 762,000,000[76]. Revenue Breakdown - Total revenue for the six months ended September 30, 2020, was HKD 41,190,000, a decrease of 66.8% compared to HKD 124,006,000 for the same period in 2019[32]. - Revenue from specialty stores was HKD 14,882,000, down 14.6% from HKD 17,423,000 in 2019[32]. - Revenue from consignment counters dropped significantly to HKD 17,220,000 from HKD 99,082,000, representing a decline of 82.6%[32]. - E-commerce revenue increased to HKD 7,304,000, up 110.6% from HKD 3,467,000 in the previous year[32]. - Other sales channels generated HKD 1,784,000, down 55.8% from HKD 4,034,000 in 2019[32]. - Revenue from health supplement products decreased by 65.7% to HKD 39,228,000, while personal care products and honey and pollen products saw declines of 86.4% and 50.1%, respectively[68]. Cash Flow and Investments - For the six months ended September 30, 2020, the net cash generated from operating activities was HKD 15,734,000, a decrease of 15.1% compared to HKD 18,490,000 for the same period in 2019[16]. - The net cash used in investing activities was HKD (21,000) for the six months ended September 30, 2020, compared to HKD 23,000 in the same period of 2019[16]. - The net cash used in financing activities was HKD (7,103,000), slightly improved from HKD (7,258,000) in the previous year[16]. - The total cash and cash equivalents increased by HKD 8,610,000, ending at HKD 63,561,000 as of September 30, 2020, compared to HKD 131,030,000 at the end of the same period in 2019[16]. - The cash and cash equivalents at the beginning of the period were HKD 54,935,000, compared to HKD 119,775,000 at the beginning of the same period in 2019[16]. Liabilities and Equity - Total liabilities increased to HKD 159,483,000, compared to HKD 152,280,000 as of March 31, 2020[11]. - The total liabilities as of September 30, 2020, were HKD 6,076,000, compared to HKD 12,874,000 as of March 31, 2020, indicating a significant reduction[54]. - The company had a total issued share capital of HKD 7,620,000 as of September 30, 2020, unchanged from the previous period[56]. - The company recognized contract liabilities of HKD 591,000 as of September 30, 2020, an increase from HKD 426,000 as of March 31, 2020, indicating growth in customer prepayments[54]. - As of September 30, 2020, the total equity attributable to owners of the company was HKD 176,368,000, down from HKD 181,666,000 as of March 31, 2020[13]. Operational Impact - The number of visitors to Hong Kong dropped by 99.7% year-on-year due to COVID-19 travel restrictions, severely impacting the retail environment[62]. - The ongoing COVID-19 pandemic has negatively impacted the company's operations, with uncertainty regarding the full extent and duration of its financial effects[105]. - The financial impact of the COVID-19 outbreak on the overall financial condition of customers in Hong Kong and mainland China remains unclear[105]. - The group operated 15 specialty stores and 81 consignment counters as of September 30, 2020, with 14 counters temporarily closed due to COVID-19[63]. - The management plans to focus on developing e-commerce to enhance online sales and allocate more resources to sales and marketing on e-commerce platforms and social media[90]. Corporate Governance and Shareholding - The company has complied with all provisions of the corporate governance code, except for the separation of roles between the chairman and the CEO, which are held by Mr. Cai Zhihui[110]. - The public shareholding ratio has decreased to approximately 14.47%, below the minimum requirement of 25% as per listing rules[115]. - A major shareholder holds 89,225,000 shares, representing about 11.71% of the total issued share capital[115]. - The company is considering various feasible options to address the insufficient public shareholding issue and has submitted proposals to the stock exchange[115]. - As of September 30, 2020, the major shareholders Beatitudes International Ltd. and Gao Yuan hold 73.82% and 11.71% of the company's shares, respectively, with Beatitudes owning 562,500,000 shares[100].

Financial Performance - AUSupreme reported a revenue of HKD 100 million for the fiscal year ending March 31, 2020, representing a 15% increase compared to the previous year[3]. - The company reported a net profit of HKD 15 million, a 20% increase year-over-year, reflecting effective operational efficiencies[3]. - The company's revenue for the fiscal year ending March 31, 2020, was HKD 210,543,000, a decrease of 27.2% compared to HKD 289,329,000 in 2019[111]. - The net profit attributable to shareholders for the year was HKD 12,047,000, down 61.4% from HKD 31,210,000 in 2019[119]. - Revenue from health supplement products decreased by 26.3% to HKD 194,770,000, while personal care products and honey/pollen products saw declines of 37.9% and 31.8%, respectively[122]. - Basic earnings per share were HKD 0.016, down from HKD 0.0416 in 2019, based on the weighted average number of shares[128]. Market Expansion and Strategy - AUSupreme plans to launch two new product lines in the next fiscal year, focusing on health and wellness, which are expected to contribute an additional HKD 20 million in revenue[3]. - The company is exploring market expansion opportunities in Southeast Asia, targeting a 10% market share within the next three years[3]. - The company aims to continue expanding its domestic and international markets, striving to build a well-known health product brand in Asia[37]. - The company plans to expand its business into overseas markets, leveraging partnerships with local celebrities for brand promotion[113]. - Strategic resources are being concentrated on e-commerce development in Hong Kong and mainland China, with initiatives to enhance online sales through live streaming and key opinion leaders (KOLs)[144]. Product Quality and Compliance - The company has successfully passed SGS heavy metal testing for its products, ensuring compliance with international safety standards[3]. - The products are certified by the Australian Therapeutic Goods Administration (TGA) and manufactured in facilities that meet international GMP standards, receiving multiple awards including "Hong Kong Excellent Brand" and "Hong Kong Star Brand"[42][46]. - The company has achieved TGA certification, ensuring its products meet international GMP standards and WHO production quality levels[94]. - The company has passed major heavy metal safety tests, ensuring its deep-sea sourced products are free from contamination and meet international standards[95]. Corporate Social Responsibility - The company emphasizes a mission of integrity, justice, and care, aiming to create a supportive corporate culture and a fair business environment[43][50]. - The company has engaged in various charitable activities, including sponsoring educational and health initiatives, to improve community life and support underprivileged groups[57][61]. - In April 2019, the company organized its first charity run, donating funds to the Love Foundation to support better education and living conditions for left-behind children in China[62]. - The company actively participates in community support and charity events, enhancing its corporate social responsibility image[83]. Awards and Recognition - The company has been recognized with multiple awards, including the "Super MD" for ten consecutive years, highlighting its commitment to talent development and training[74]. - The company received the "Outstanding Listed Company Award," which acknowledges its market value and performance recognized by the capital market[76]. - The company was awarded the "Asia Excellent Brand" title, recognizing its innovative practices and leadership in brand development[80]. - The company has been awarded the "Hong Kong Excellent Brand" title, reflecting its continuous excellence in developing original brands[90]. - The company has been recognized for its high-quality service standards by the Hong Kong Tourism Board, reinforcing its reputation as a quality tourism city[96]. Operational Efficiency and Cost Management - The company has implemented stricter cost control measures in response to the fluctuating market conditions due to social unrest and COVID-19[119]. - The group's sales and distribution expenses decreased by 22.9% to HKD 139,173,000, primarily due to reduced consignment commissions[126]. - The group's income tax expense decreased by 59.8% to HKD 2,385,000, attributed to a decline in profit before tax[127]. - The company is focusing on cost reduction and operational efficiency in response to economic challenges posed by the COVID-19 pandemic[143]. Governance and Management - The board of directors emphasizes the importance of corporate governance, ensuring accountability and transparency in all business operations[166]. - The board held four meetings during the year, with all directors attending all meetings, achieving a 100% attendance rate[181]. - The audit committee consists of three independent non-executive directors, ensuring compliance with corporate governance codes[184]. - The company encourages directors to participate in relevant training courses, with costs covered by the company[180]. - The chairman and CEO roles are held by the same individual, Mr. Cai Zhihui, which the board believes is in the best interest of the company[182].

Financial Performance - Revenue for the six months ended September 30, 2019, was HKD 124,006,000, a decrease of 10.7% from HKD 138,836,000 in the same period of 2018[7] - Gross profit for the same period was HKD 106,698,000, down 11.0% from HKD 119,911,000 year-on-year[7] - Operating profit decreased to HKD 11,603,000, representing a decline of 24.0% compared to HKD 15,289,000 in the previous year[7] - Profit attributable to owners of the company was HKD 8,922,000, down 27.5% from HKD 12,242,000 in the prior period[7] - Basic and diluted earnings per share were HKD 1.19, compared to HKD 1.63 in the same period last year[7] - The total comprehensive income for the period was HKD 8,898,000, down from HKD 12,242,000 in the previous year, indicating a decline of about 27.5%[12] - The company reported a net profit of HKD 8,922,000 for the six months ended September 30, 2019, compared to HKD 12,242,000 for the same period in 2018, representing a decrease of approximately 27.5%[12] - The company reported a pre-tax profit of HKD 2,234,000 for the six months ended September 30, 2019, down from HKD 3,047,000 in the same period of 2018[62] Assets and Liabilities - Total assets as of September 30, 2019, were HKD 187,331,000, slightly down from HKD 188,535,000 as of March 31, 2019[10] - The company reported a net asset value of HKD 173,762,000, down from HKD 188,154,000 as of March 31, 2019[10] - The company recognized a depreciation expense of HKD 6,849,000 for right-of-use assets, with total depreciation for property, plant, and equipment at HKD 1,118,000[61] - The company reported a net increase in total assets of HKD 26,747,000, while total liabilities increased by HKD 27,537,000 due to the application of HKFRS 16[51] Cash Flow - Cash and cash equivalents increased to HKD 131,030,000 from HKD 119,775,000, indicating a positive cash flow trend[10] - Cash generated from operating activities was HKD 18,490,000, an increase of 25.5% from HKD 14,689,000 in the same period last year[15] - The net cash and cash equivalents increased by HKD 11,255,000, reaching HKD 131,030,000 at the end of the reporting period[15] - The financing activities resulted in a net cash outflow of HKD 7,258,000, reflecting the company's dividend payments and other financing activities[15] Revenue Breakdown - Revenue from specialty stores decreased to HKD 17,423,000 from HKD 19,984,000, while consignment counters revenue fell to HKD 99,082,000 from HKD 113,174,000[54] - Revenue from health supplement products decreased by 10.4% to HKD 114,291,000 compared to HKD 127,502,000 in 2018[82] - Revenue from personal care products fell by 15.9% to HKD 7,948,000 from HKD 9,452,000 in 2018[82] - Revenue from honey and pollen products declined by 6.1% to HKD 1,767,000, consistent with the previous year's percentage[82] - E-commerce revenue slightly increased by 4.3% to HKD 3,467,000 from HKD 3,324,000 in 2018[86] - Other sales channels saw a significant increase of 71.4% to HKD 4,034,000, up from HKD 2,354,000 in 2018[86] Market Conditions - The overall retail market in Hong Kong experienced a decline of approximately 10.7% during the reporting period, mirroring the company's revenue drop[79] - In September 2019, the number of visitors to Hong Kong decreased by 34.2% compared to the same month last year, significantly impacting the retail sector[99] - The company continues to monitor economic conditions closely and is taking flexible measures to respond to the volatile business environment[79] Strategic Initiatives - The company plans to focus on expanding its market presence and enhancing product offerings in the upcoming periods[8] - The company has initiated new strategies to improve operational efficiency and reduce costs in response to declining revenues[8] - The company has implemented strict cost control measures to ensure effective use of financial resources amid challenging economic conditions[99] - The company plans to focus on developing online sales by collaborating with more online shopping platforms and implementing various marketing strategies in Hong Kong, China, and other regions[99] - The overseas business development in other Asian regions is expected to provide stable and sustainable growth for the company[99] Corporate Governance - The company has complied with all provisions of the corporate governance code, except for the separation of roles between the chairman and the CEO[115] - The board believes that Mr. Cai Zhiwei's dual role as Chairman and Managing Director aligns with the best interests of the group due to his extensive knowledge and business network in the personal care industry[118] - The audit committee consists of three independent non-executive directors responsible for reviewing and supervising the group's financial reporting system and internal control procedures[120] - The audit committee has reviewed the group's unaudited condensed consolidated financial performance for the period[121] Shareholding Structure - As of September 30, 2019, the major shareholders Beatitudes International Limited and Gao Yuan hold 75% and 10.01% of the issued shares, respectively[101][105] - The public float of the company decreased from 25% to approximately 14.99%, below the minimum requirement of 25% as per listing rules[109] - The company is committed to taking appropriate measures to restore at least 25% public shareholding as soon as reasonably practicable[110] - No stock options were granted under the stock option plan since the company's listing, and there were no unexercised stock options as of September 30, 2019[112]

Financial Performance - AUSupreme reported a revenue increase of 15% year-over-year, reaching HKD 500 million for the fiscal year ending March 31, 2019[35]. - The company's revenue reached a historic high of HKD 289,329,000, an increase of 19.3% compared to HKD 242,500,000 in 2018[94]. - The profit attributable to shareholders significantly increased by 149.1% to HKD 31,210,000[94]. - The consolidated profit attributable to the company's owners increased by 149.1% to HKD 31,210,000, up from HKD 12,530,000 in the previous year[101]. - Revenue from health supplement products grew by 18.6% to HKD 264,346,000, while personal care products saw a 39.1% increase to HKD 20,642,000[105]. - The consignment sales channel recorded significant growth of 24.1% to HKD 236,293,000, compared to HKD 190,429,000 in the previous year[108]. - E-commerce revenue increased by 2.8% to HKD 7,409,000, while revenue from specialty stores slightly decreased by 1.7% to HKD 37,911,000[108]. - Basic earnings per share for the year ended March 31, 2019, was HKD 0.0416, compared to HKD 0.0167 in 2018[113]. Market Expansion and Strategy - The company expanded its retail presence to 150 specialty stores and 83 consignment counters, aiming to enhance brand visibility in Asia[35]. - AUSupreme plans to continue aggressive overseas market expansion, targeting to become a well-known health product brand in Asia[35]. - The company aims to achieve a 20% growth in user base by the end of the next fiscal year through enhanced marketing efforts[35]. - The company plans to continue optimizing its retail network and expanding into overseas markets through partnerships[99]. - The brand's promotional strategies, including the appointment of a well-known spokesperson, have positively impacted brand awareness and sales performance[101]. Product Development and Quality - Future product development includes the launch of new health supplements, with a focus on quality and compliance with international standards[35]. - The company's products are certified by the Australian Therapeutic Goods Administration (TGA) and manufactured in facilities that meet international GMP standards[64]. - The company is committed to high-quality production standards, ensuring its products meet global health regulations[64]. - The company has focused on expanding its market presence and enhancing product quality to drive future growth[91]. Corporate Social Responsibility - The company emphasized its commitment to social responsibility through community care and charitable services, aligning with its core value of "giving back to society"[35]. - The founder of the company, Mr. Cai Zhihui, has published a book, with all proceeds donated to charity organizations[51]. - The company actively participates in various charitable activities, promoting social responsibility and community care[51]. - The company is actively involved in community and educational initiatives, enhancing its corporate social responsibility profile[133]. Governance and Management - The company emphasizes good corporate governance to enhance shareholder value and ensure effective accountability within its management structure[153]. - The company has established a strong governance structure with experienced directors overseeing various operational aspects[134]. - The board consists of seven directors, with independent non-executive directors accounting for over 40% of the board members[159]. - The company has adopted the corporate governance code and has complied with all applicable code provisions during the year, except for specific deviations disclosed in the annual report[154]. - The company emphasizes the importance of skilled and experienced employees as a key asset and will provide various training programs to enhance product knowledge and customer service capabilities[128]. Awards and Recognition - The company has received multiple awards, including "Hong Kong Star Brand" and "Outstanding Listed Company Award," recognizing its market leadership and commitment to quality[63]. - The company has been recognized as a leading brand in the health food industry in Hong Kong, demonstrating its strong market position[53]. - The company has received multiple awards for its brand image and health product range in recent years, reflecting its successful marketing strategies[136].